Expression of Intestine-Specific Antigen Reveals Novel Pathways of CD8 T Cell Tolerance Induction  by Vezys, Vaiva et al.
Immunity, Vol. 12, 505±514, May, 2000, Copyright ª 2000 by Cell Press
Expression of Intestine-Specific Antigen Reveals
Novel Pathways of CD8 T Cell Tolerance Induction
at this surface and results in a symbiotic development
of the mucosal immune system in which untoward re-
sponses to ingested antigens or to normal flora are pro-
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hibited. Although many activated lymphocytes reside inUniversity of Connecticut Health Center
the intestinal mucosa (James et al., 1990; Huleatt andFarmington, Connecticut 06030
LefrancË ois, 1995; Lundqvist et al., 1996), tissue damage
does not occur under normal circumstances. Thus, this
organ provides a distinctive model for analysis of toler-Summary
ance to a self-antigen in a dynamic system.
Generation and maintenance of tolerance to self-pro-Reactivity to intestinal epithelium-specific antigen
teins found in the mucosa is crucial, since the gut serveswas studied by transgenic expression of cytosolic
the body in two distinctly important ways. First, nutrientovalbumin controlled by an enterocyte-specific pro-
and fluid absorption occurs at this site allowing for nour-moter. Transferred OVA-specific CD8 cells (OT-I) pref-
ishment and homeostasis of all tissues. Second, theerentially expanded in mucosal lymphoid tissues and
mucosa presents a barrier to normal and pathogenicthe epithelium but failed to cause tissue damage. In
microorganisms. This barrier function is manifestedcontrast, concomitant VSV-ova infection induced OT-
through physical means (e.g., mucus), innate immuneI-mediated epithelial cell destruction that correlated
mechanisms such as defensins, and adaptive antigen-with antigen density. OT-I cells retained in the epithe-
specific immunity. A breech in any of these functionslium exhibited high levels of lytic activity but were
may lead to autoimmune-type reactions and subse-unable to produce cytokines. The mice were systemi-
quently IBD (Podolsky, 1991; Hermiston and Gordon,cally tolerant to OVA since endogenous CD8 cells were
1995; Mashimo et al., 1996). Recent analysis of animalnonresponsive to VSV-ova infection. Thus, intestinal
models suggests that experimental IBD can occur as aantigen gained access to peripheral tissues via ab-
result of dysregulation of the delicate balance betweensorption from effete epithelial cells. This system dem-
chronic activation of the mucosal immune system andonstrated a requirement for inflammation to drive
control of autoreactivity (Strober and Ehrhardt, 1993).pathogenic autoreactivity against enterocytes and
However, this is not the only potential mechanism under-identified pathways of intestine-specific immunoregu-
lying disease progression, as disruption of the integritylation.
of barrier function at the level of the epithelial cell (Her-
miston and Gordon, 1995) or nonspecific antimicrobialIntroduction
peptides (Mashimo et al., 1996) can result in IBD-like
syndromes. Whether the tissue changes and destructionTolerance is an important requirement for the regulation
that ensues after the initiation of IBD is related to anti-
of autoimmunity. Understanding tolerance induction,
gen-specific reactivity directed toward autoantigens is
maintenance, and breakdown is of paramount impor-
unknown. To begin to understand the regulation of toler-
tance, since absence or loss of tolerance is thought to ance to self in the intestinal mucosa, we have developed
result in organ damage leading to debilitating diseases a transgenic mouse model in which expression of the
such as diabetes, multiple sclerosis, rheumatoid arthri- nominal antigen ovalbumin (OVA) is intestine specific.
tis, and inflammatory bowel disease (IBD). Mechanisms
are in place to delete or downregulate autoreactive T Results
and B (Van Parijs and Abbas, 1998) lymphocytes, with
negative selection in the thymus being the predominant Intestine-Specific Ovalbumin Transgene Expression
process for eliminating self-reactive T cells (Blackman In order to test the immunological consequences of in-
et al., 1990; Nossal, 1994). However, it is not clear how testine-specific antigen expression, we developed two
tolerance is maintained to developmentally regulated or different lines of transgenic mice expressing a trun-
tissue-specific proteins or what events control autore- cated, nonsecreted form of OVA (tOVA; Shastri and Gon-
active T cells that have bypassed negative selection. zalez, 1993) under control of the intestinal fatty acid
Tolerance in these cases may be mediated by ignorance binding promoter (iFABP) (Figure 1A). This promoter di-
of antigen because such T cells may not migrate to the rects protein expression to small intestinal mature en-
site of antigen expression (Van Parijs and Abbas, 1998) terocytes but not to crypt epithelial cells, and there is
or may be due to cross-tolerance induced in lymph differential expression of the promoter along the length
nodes draining the site of antigen expression (Kurts et of the small intestine (Sweetser et al., 1988; Green et
al., 1997). These questions have not been addressed in al., 1992). The expression pattern of mRNA encoding
the intestinal mucosa, which presents unique anatomi- OVA was evaluated by mRNA dot blot analysis. OVA
cal and physiological features that affect the interface mRNA was detected only in the small intestine (Figure
of this organ with the immune system. The handling of 1B) and was not detected in thymus, lung, kidney, liver,
large quantities of microbial and food antigens occurs or brain (data not shown). mRNA quantitation revealed
that line 232-4 expressed 10-fold higher levels of OVA
mRNA than line 232-6, and this was confirmed by North-* To whom correspondence should be addressed (e-mail: llefranc@
neuron.uchc.edu). ern blot analysis (data not shown). Highest mRNA levels
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Tissue-Specific Activation of Adoptively Transferred
Ova-Specific CD8 T Cells
In order to be able to track the immune response to
OVA and determine the sites of immune reactivity to
IEC-expressed OVA, we utilized a T cell adoptive trans-
fer system (Pape et al., 1997; Kim et al., 1998). Small
numbers (5 3 105) of CD81 TCR transgenic T cells reac-
tive with the OVA peptide SIINFEKL in the context of
MHC class I H-2Kb (OT-I cells) (Hogquist et al., 1994)
were transferred to 232-4 and 232-6 mice. Four and five
days later tissues were analyzed for the presence of
donor cells. In normal, nontransgenic mice, OT-I cells
comprised z0.1% of cells in spleen, mesenteric lymph
node (MLN), peripheral lymph node (PLN), and Peyer's
patch (PP) but were not detectable in lamina propria
(LP) or intraepithelial lymphocyte (IEL) compartment, in
agreement with our previous results showing that OT-I
cells traffic into the gut mucosa only after activation
Figure 1. Construct Used in Generation of IFABP-tOVA Transgenic (Kim et al., 1997, 1998). By day 4 after transfer into
Mice and OVA mRNA Expression along the Length of the Small
232-4 mice, a substantial expansion of OT-I cells hadIntestine in Two Lines of Transgenic Mice
occurred in the PP and MLN, with on average 50% and
(A) The SalI fragment used for production of C57BL/6J transgenic
30% of CD8 cells, respectively, being donor (Figure 2).mice contained the following: the long form of the IFABP promoter,
In LP and IEL, z15% of the CD8 subset were OT-I cellstruncated OVA cDNA encoding amino acids 138±336, and the human
at day 4. In the nonmucosal lymph nodes and the spleen,growth hormone DNA (hGH).
(B) Dot blot analysis of poly(A) RNA from duodenum, proximal jeju- z5% or less of CD8 cells were OT-I cells. By day 5 after
num, distal jejunum, and ileum from the two lines (232-4 and 232-6) transfer, large populations of OT-I cells (.50% of total
of IFABP-tOVA mice using OVA cDNA as a probe. CD8 cells) were present in the LP and the intestinal
epithelium. OT-I cells in PP remained at high levels,
were detected in the distal jejunum and ileum of 232-4 while OT-I cells in MLN had decreased significantly at
mice, whereas the highest expression levels were de- this time point, and there were small numbers of OT-I
tected in the proximal and distal jejunum of 232-6 mice cells in the PLN and spleen. Despite the presence of
with z2-fold less mRNA in the ileum (not obvious for large numbers of antigen-reactive CD8 T cells in the
232-4 in the overexposure shown necessitated by the epithelium, tissue destruction or any signs of disease
low level of mRNA in 232-6 mice). Lower levels of OVA were not observed (see below).
mRNA were present in the duodenum of 232-4 mice Transfer of OT-I cells into 232-6 mice yielded similar
(z7-fold lower than that of distal jejunum), and OVA but less robust responses (Figure 2). Thus, at day 4 after
mRNA was barely detectable in the duodenum of 232-6 transfer, OT-I cells made up z40% of PP CD8 cells and
mice. This difference in mRNA levels was not related z10% of MLN CD8 cells. Only minor populations of OT-I
to transgene copy number as both lines contained z5 cells were detected in PLN, LP, or IEL populations. By
copies of the transgene (data not shown). Attempts at day 5, the responses in the PP and MLN had declined,
detection of tOVA by Western blotting or immunohisto- while the OT-I population in the IEL and LP had in-
chemistry were unsuccessful perhaps due to rapid pro- creased to z10% of the CD8 populations in those sites.
tein degradation by intestinal epithelial cells or due to Minor populations of OT-I cells were found in spleen
and PLN. These results correlated with the lower OVAvery low protein expression.
Figure 2. Adoptively Transferred OVA-Spe-
cific CD8 T Cells Preferentially Expand in Mu-
cosal Tissues
Ly5.21 OT-I cells (5 3 105) were transferred
to 232-4 or 232-6 mice, and tissues were ana-
lyzed for the presence of CD81Ly5.21 cells
by fluorescence flow cytometry at 4 and 5
days after transfer. The values represent the
means and standard errors of three determi-
nations for spleen and at least six determina-
tions for all other tissues.
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to the IFABP-tOVA mice. The mice were monitored for
weight changes during the course of the experiment
and for general signs of disease. Infected mice from line
232-4 exhibited severe malaise and profound weight
loss (Figure 3A), resulting in death in most cases by day
6 postinfection. In contrast, mice from the 232-6 line
suffered only a small and transient weight loss with no
mortality (Figure 3B). These results correlated well with
the demonstration that mice from line 232-4 expressed
higher levels of OVA mRNA than did 232-6 mice and
indicated that antigen dose may be critical for the out-
come of the response.
Antigen-Specific Tissue Destruction Is Dependent
upon Inflammatory Mediators and Antigen Load
After OT-I transfer and VSV-ova infection, gross pathol-
ogy in the form of substantial fluid buildup and severe
inflammation was observed only in the small intestine
in both lines of transgenic mice. To determine the under-
lying cause of the disease, histological analysis was
performed on intestinal tissue following OT-I cell transfer
with or without VSV-ova infection (Figure 4). No effect
of OT-I cell transfer and VSV-ova infection was observed
in nontransgenic B6 mice or in either 232-4 or 232-6
mice that received only OT-I cells without infection. The
latter result was perhaps surprising given the fact that
the intestinal epithelium was heavily infiltrated with anti-
gen-specific OT-I cells at this point (Figure 2 and see
Figure 3. Virus Infection Induces Disease after Transfer of OT-I Cells below). In contrast, the inclusion of VSV-ova infection
to IFABP-tOVA Mice
resulted in profound morphological changes within the
OT-I cells (5 3 105) were transferred to 232-4 or 232-6 mice, and 1
mucosa in 232-4 and 232-6 mice (Figure 4). The epithelialday later the mice were infected with VSV-ova. The mice were
layer was largely destroyed in the duodenum and jeju-weighed every other day beginning on the day of infection (day 0).
num with somewhat less damage evident in the ileumThe majority of the 232-4 mice (A) died by day 6 after infection, and
all others, including the 232-6 mice (B), were sacrificed at day 35. of 232-4 mice 4 days after infection. In 232-6 mice, signif-
Each symbol represents an individual animal. icant destruction of enterocytes was noted in the duode-
num and jejunum but was minimal in the ileum. Villus
structure was less severely affected in 232-6 versus
mRNA levels detected in the small intestine of 232-6 232-4 mice, again in keeping with the differences in OVA
mice as compared to the 232-4 mice and also demon- mRNA expression between the two lines.
strated the sequential nature of the responseÐi.e., pri- The antigen-dependent destruction of the epithelium
mary activation in PP and MLN followed by migration was clearly evident in the tissue sections, since the
and expansion of OT-I cells in the LP and the epithelium. intestinal crypts were intact, and the IFABP promoter is
Results of analysis of CFSE-stained OT-I cells after not active in immature crypt enterocytes (Sweetser et
transfer correlated with these findings (data not shown). al., 1988; Green et al., 1992). There was also an accom-
By day 17 in both transgenic strains, transferred cells panying cellular infiltration of the lamina propria and
were not detectable, indicating that deletion had oc- muscle layer, extreme crypt hyperplasia, and atrophy
curred (data not shown). Although it is possible that OVA of the villi. Tissue damage was not observed in other
may be produced in tissues other than the gut and we organs. These results indicated that the amount of OVA
were unable to detect the mRNA, the primary sites of produced by IEC significantly influenced the outcome
OT-I cell activation (PP and MLN) and the correlation of of the immune response and thereby affected the bal-
mRNA levels in the intestinal epithelium with the level ance of factors maintaining homeostasis. The addition
of OT-I cell activation in 232-4 versus 232-6 mice sug- of inflammatory mediators in the form of virus along with
gested that the source of the antigen was the intestinal antigen recognition was apparently the decisive element
epithelial cell. in induction of tissue destruction and resulting disease.
IFABP-tOVA Mice Exhibit Increased ExpansionVirus Infection Triggers CD8 T Cell±Mediated
Intestinal Disease of Donor OT-I Cells in the Periphery
and the MucosaSince the encounter of transferred OT-I cells with endog-
enous OVA resulted in activation followed by deletion, Since an obvious physiological effect occurred as a con-
sequence of virus infection, we wished to determinewe wished to test whether inclusion of inflammatory
signals generated via virus infection would alter the out- whether intestine-specific effects were evident with re-
spect to the transferred OT-I T cells. After adoptivecome of the response. To this end, mice were infected
with VSV-ova following transfer of 5 3 105 OT-I cells transfer of 5 3 105 OT-I cells into B6 mice without virus
Immunity
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Figure 4. Virus Infection and OT-I Transfer In-
duces Destruction of the Intestinal Epithelium
OT-I cells (5 3 105) were transferred to B6,
232-4, or 232-6 mice, and 1 day later the mice
were infected with VSV-ova or were not in-
fected. Four days later tissue sections from
duodenum, jejunum, and ileum from B6 and
IFABP-tOVA transgenic animals were stained
with H&E. All images are magnified 2003.
infection, 0.1% of PLN cells were of donor origin 5 days and 85% of the IEL in 232-4 and 232-6 mice, respec-
tively. Since such an impressive expansion was not ob-after transfer and these were CD44lo (Figure 5A and data
not shown). However, as shown here and in Figure 2, served in immunized B6 mice, the increase in OT-I cells
was likely due to the increased expansion in the periph-an increase in transferred OT-I cells occurred in naive
232-4 and 232-6 mice, which was accompanied by ery because of the presence of endogenous OVA and
the subsequent trafficking of increased numbers of cellsupregulation of the activation antigen CD44 (data not
shown). At day 4 after VSV-ova infection, an increase in into the epithelium, where recognition of IEC-expressed
OVA induced further proliferation.LN OT-I cells was evident in B6 mice (up to 3.6% of
total), and this increase was significantly accentuated We also sought to visualize the expansion and infiltra-
tion of the mucosa with antigen-specific CD8 T cells.in the IFABP-tOVA transgenic mice to 30% and 40% of
total lymphocytes in 232-4 and 232-6 mice, respectively Therefore, cryostat sections of intestine from OT-I-
transferred 232-4 mice on days 2, 3, and 4 after VSV-(Figure 5A). This result indicated that the presence of
endogenous OVA resulted in substantial potentiation of ova infection or 5 days after transfer without infection
were stained with anti-Ly5.2 mAb (donor specific). Twothe OT-I cell response.
In the intestinal mucosa of uninfected B6 mice, OT-I days after infection, Ly5.21 cells could not be detected
(Figure 6A), while on day 3 a small number of donor cellscells were not detected (Figure 5B), in keeping with our
previous results demonstrating that naive OT-I cells do were found (Figure 6B). At day 3 most OT-I cells were
found in the epithelial layer rather than the LP (Figurenot enter the mucosa (Kim et al., 1998). In contrast, in
naive 232-4 and 232-6 mice, significant mucosal popula- 6B). By day 4 after infection, a massive expansion/infil-
tration of OT-I cells had occurred (Figure 6C). The epithe-tions of OT-I cells were found on day 5 after transfer,
and as with the LN, a larger population was present in lium was severely damaged or absent at this time point.
OT-I cells were generally not evident in the crypts but232-4 mice. The IEL compartment of infected B6 mice
contained 11% OT-I cells, again showing the necessity were present in the surrounding LP tissue and could be
seen in the muscle layer. When 232-4 mice were notof activation of these cells in the periphery before migra-
tion to the mucosa. In stark contrast, infection of 232-4 infected after OT-I cell transfer, the epithelium was ex-
tensively infiltrated by OT-I cells according to flow cyto-and 232-6 mice resulted in a massive expansion of OT-I
cells in the epithelium, with OT-I cells comprising 98% metric data (Figure 5B). As shown in Figure 6D, the
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Figure 5. Transgenic Ova Expression Amplifies the OT-I Response to VSV-Ova Infection
OT-I cells (5 3 105) were transferred to B6, 232-4, or 232-6 mice, and 1 day later the mice were infected with VSV-ova or were not infected.
Five days after cell transfer, mice were sacrificed, and PLN (A) or IEL (B) were analyzed for donor phenotype (Ly5.21) and CD8 expression
by fluorescence flow cytometry. Percentages shown are based on total lymphocytes. Means of values for two mice (B6 controls) or seven
mice each (232-4 and 232-6) are shown.
epithelium appeared normal in this situation. That is, Induction of Split Anergy in Autoreactive
OT-I Cellsalthough large numbers of OT-I cells were detected in
the epithelium, no tissue damage was evident. These Since all 232-6 mice survived following OT-I cell transfer
and VSV-ova infection, we were able to examine theresults indicated that some form of functional tolerance
was maintained even though potentially autoreactive T long-term impact of IEC antigen expression on autore-
active T cells. By days 14±21, 232-6 mice had completelycells were directly apposed to antigen-expressing en-
terocytes. Furthermore, the associated physical mani- recovered and the intestinal tissue appeared normal. At
this time, most mice contained small numbers of OT-Ifestations seen in animals infected with VSV-ova did not
occur in uninfected mice, indicating that the presence cells in the epithelium, while only a subset of animals
retained OT-I cells in the MLN. At later time points (.30of large numbers of antigen-specific cells in the area of
antigen expression was not sufficient to break tolerance. days), OT-I cells were either completely deleted or a
Figure 6. Damage of the Intestinal Epithelium
by Infiltrating OVA-Specific CD8 T cells Is De-
pendent on Concomitant Virus Infection
OT-I cells (5 3 105) were transferred to 232-4
mice, and 1 day later the mice were infected
with VSV-ova (Panels A-C) or were not in-
fected (D). Three (A), four (B), or five days (C
and D) after OT-I transfer, cryostat sections




significant population of cells remained in the IEL com-
partment but were not present in any other tissue exam-
ined (data not shown). The fact that OT-I cells were not
found in other tissues suggested that recognition of IEC-
expressed OVA was unable to induce deletion but also
did not result in overt tissue damage. Since the epithe-
lium-resident OT-I cells at these times were apparently
anergic in vivo, we wished to test whether such cells
could respond to TCR stimuli in vitro. To this end, IEL
containing OT-I cells from VSV-ova-infected B6 or 232-6
mice were tested for IFNg production following 5 hr
stimulation with ova-peptide in vitro. Surprisingly, while
85% of OT-I cells from B6 mice were induced to produce
IFNg, none of the OT-I cells in 232-6 mice could be
triggered to produce IFNg (Figure 7A). Similar results
were obtained when TNFa induction was assayed (data
not shown). We also assessed the lytic activity of OT-I
cells in 232-6 mice (Figure 7B). In contrast to their inabil-
ity to produce cytokines, these cells exhibited high lev-
els of lytic activity toward ova-peptide-bearing target
cells. The level of lytic activity on a per cell basis was
similar to that obtained from OT-I cells in VSV-ova-
infected B6 mice (Kim et al., 1998). These results indicated
that chronic encounter of antigen by OT-I IEL in 232-6
mice resulted in a state of split anergy in which lytic
activity but not cytokine production could be triggered.
CD8 T Cells of IFABP-tOVA Mice Are Tolerant
to Ova
Since the adoptive transfer data suggested that antigen
was only expressed in the intestine in the IFABP-tOVA
mice but had gained access to mucosal secondary
lymphoid tissue, we wished to test whether endogenous
CD8 T cells were able to respond to OVA. To this
end, mice were infected with VSV-ova, and the H-2Kb-
restricted splenic CD8 response to the VSV N protein
and to OVA was measured by MHC tetramer staining 6
days later (Figure 8). In B6 mice, z7% of splenic CD8
T cells were OVA specific and 13% were VSV N specific.
Figure 7. Split Anergy Is Induced in OT-I Cells Remaining in theIn contrast, OVA-specific CD8 cells were not detectable
Intestinal Epithelium of IFABP-tOVA Transgenic Mice and Endoge-
in 232 mice, but normal levels of VSV-N-specific CD8 T nous Tolerance to OVA Is Observed in IFABP-tOVA Transgenic Mice
cells were present. Similar results were obtained from (A and B) OT-I cells (5 3 105) were transferred to B6 or 232-6 mice,
LN and mucosal T cells (data not shown). This result and 1 day later the mice were infected with VSV-ova. Twenty-
suggested that IEC-expressed antigen had entered the one days (A) or 14 days (B) later mice were sacrificed, and IEL
were analyzed for the production of intracellular IFNg by donorsystemic immune system, probably via absorption of
Ly5.21CD81 cells by fluorescence flow cytometry. Cytolytic activityprotein liberated from turnover of IEC, and had induced
was assayed against ova-peptide-pulsed EL4 target cells (closedtolerance. However, we cannot rule out the possibility
symbols) or control target cells without peptide (open symbols).
that very low levels of antigen are expressed elsewhere, Closed squares and open squares, IEL pooled from two 232-6 mice;
such as the thymus, which leads to tolerance. closed circles and open circles, IEL from a single 232-6 mouse.
(C) B6 or IFABP-tOVA mice were infected with VSV-ova, and 6 days
later spleen cells were analyzed. Responses to OVA and VSV-NDiscussion
protein were measured using H-2Kb tetramers containing the appro-
priate peptides. Cells were reacted with anti-CD8, anti-CD11a, and
The data presented introduced a novel model for the tetramer and analyzed by three-color fluorescence flow cytometry.
study of T cell reactivity to intestine-specific autoanti- The values indicate the percentage of cells that are tetramer positive
gen. Since it has been difficult to identify self-proteins within the CD8 population. At least three determinations for each
strain were performed.that may play a role in the etiology or chronicity of IBD,
it has not been possible to assess the impact antigen
specificity has in these situations. These results demon- encounter might be downmodulation of immunity (Li et
strate that recognition of an IEC-specific antigen by cy- al., 1995), rather than pathology. Indeed, the results of
totoxic T cells in vivo can result in tissue damage, al- our adoptive transfer experiments in the absence of
though it remains unclear whether direct recognition of VSV-ova infection (Figure 2) and the induction of partial
self-antigen occurs in IBD. Prior studies of CD8 T cell± anergy following the destructive episode (Figure 7) sup-
port this hypothesis. Our findings also make it apparentIEC interactions suggested that the outcome of such an
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that IEC can have APC-like qualities in vivo, which may fragments were absorbed through the intestinal epithe-
lium due to the shedding of epithelial cells, which canfunction to potentiate destruction or tolerance at this
amount to more than 2 3 108 cells per day in the mousesite, depending on the initial stimuli. Moreover, the loca-
(Potten and Morris, 1988). The fact that transferred cellstion and the amount of antigen present can greatly influ-
were preferentially activated and expanded in the PPence the magnitude and the eventual outcome of the
and MLN supported this theory. The recent demonstra-immunological response. Thus, although lower IEC anti-
tion that dendritic cells in the intestinal mucosa cangen levels were sufficient to induce substantial expan-
transport apoptotic IEC to the MLN suggests a mecha-sion of antigen-reactive CD8 T cells, reduced tissue
nism by which antigen presentation may occur in ourdamage and tolerance induction were the endpoint of
system (Huang et al., 2000). Our finding that virus infec-the response. In contrast, higher antigen levels resulted
tion was required to induce tissue damage is in keepingin sustained CD8 T cell activation and irreparable tissue
with recent data indicating that inflammatory signalspathology in most cases. Recently, a report showing
are essential for productive immune responses in vivointestinal pathology caused by hsp60-specific CD8 cells
(Bennett et al., 1998; Khoruts et al., 1998; Ridge et al.,indicated that antigen-specific cells can participate in
1998; Schoenberger et al., 1998). In addition, a recentIBD-like disease (Steinhoff et al., 1999). This model has
report indicated that adjuvants in the form of viral orvarious characteristics that differ from ours. We were
bacterial infections could break tolerance to a widelyable to follow the progression of the cellular response
dispersed self-protein (Ehl et al., 1998), although ourfrom initiation to the cytotoxic end, whereas the hsp60
system presents a more fitting physiological assess-model transfers in vitro activated cells, hence losing any
ment of segregated antigen, since sequestered proteinimpact of in vivo priming. Also, the preactivated cells
would need to be cross-presented.will migrate to all tissues in the body (Wack et al., 1997),
The immune response mounted to IEC-expressed an-and since they already secrete TNFa and IFNg, these
tigen resulted in deletion in secondary lymphoid tissues,cytokines could cause the initial cell damage in the liver
and this was likely a consequence of cross-toleranceand mucosa, since it is known that IEC are extremely
due to processing and presentation of antigen derivedsensitive to TNFa (Neurath et al., 1997; Mackay et al.,
from epithelial cells by professional APC, as has been1998; Piguet et al., 1998). This may cause an increase
shown for other tissues (Adler et al., 1998; Heath etin hsp60 and so propagate ensuing damage. Moreover,
al., 1998). However, these models cannot be directlythe pathology associated with this model only occurs in
compared to ours due to differences in tissue dynamicsimmunocompromised animals (scid and TCRb2/2 mice)
and the form of antigen expressed. Many transgenicand is not organ specific.
nominal ªself-antigens,º including those using ova, haveWhat factors are involved in CTL-mediated IEC de-
been expressed as transmembrane or soluble proteins.struction? CD8 cells are known to use several mecha-
Thus, in those systems it is conceivable that intact pro-nisms for destruction of antigen-bearing targets. Per-
tein could be transferred to APC via shedding or otherforin is one of the major CTL mediators of cellular lysis
mechanisms, while in our model presumably only intra-(Kagi et al., 1996), and CD8 T cells can also produce
cellular protein fragments or cell fragments would beother mediators of tissue damage, including TNF and
available. The interaction of OT-I cells with intestinallymphotoxin (LT) (Ware et al., 1995; Krakauer et al.,
epithelial cells also presented distinctions with regard to1999). CD8 cells can also cause cell death via FASL±FAS
OT-I cell interaction with the pancreas and other tissues.interactions (Kagi et al., 1995). Various cytokines have
While transfer of 5 3 106 OT-I cells into RIP-ova micebeen implicated in animal models of IBD, such as TNF
in the absence of additional inflammatory signals causes(Neurath et al., 1997; Guy-Grand et al., 1998; Mackay et
diabetes (Kurts et al., 1997), the infiltration of the intesti-al., 1998), IFNg (von Herrath and Oldstone, 1997; Guy-
nal epithelium with large numbers of autoreactive OT-IGrand et al., 1998), and IL-1 (Probert et al., 1995). TNF
cells in the absence of VSV-ova infection did not cause
inhibition has also been shown to be effective in treat-
tissue damage in our mice, suggesting anatomically dis-
ment of IBD in some patients (Rutgeerts, 1998). Our
tinct mechanisms of tolerance induction. Surprisingly,
demonstration of lytic activity in OT-I cells from the epi- even after the initial destructive episode after virus infec-
thelium at a time when tissue destruction was not evi- tion, OT-I cells remaining in the epithelium were not
dent implied that direct lytic activity, perhaps perforin overtly autoreactive. Therefore, unlike in other models,
mediated, may not have a major role in IEC damage, tolerance was induced at two levels in our system. First,
although this remains to be tested. Furthermore, the as seen with antigens in other tissues (Adler et al., 1998;
downmodulation of cytokine inducibility in long-lived Heath et al., 1998), primary T cell activation and subse-
OT-I IEL may suggest the involvement of soluble media- quent deletion in our system occurred in the lymphoid
tors in tissue damage. Additional experimentation will tissue, draining the site of antigen expression (MLN and
be required to determine the relative resistance or sensi- PP). Second, following initial activation, OT-I cells mi-
tivity of IEC to CD8-derived instruments of cell death. grated to the intestinal epithelium, where they once
The finding that apparently IEC-derived antigen was again encountered antigen, destroyed tissue, and sub-
sufficient to induce complete peripheral tolerance (at sequently remained in the epithelium as partially anergic
least in the CD8 T cell compartment) was initially surpris- cells. Thus, ªsplit toleranceº based on anatomical loca-
ing, especially considering our inability to detect intact tion was evident in which deletion was the norm in
tOVA by various methods (data not shown). However, lymphoid tissue while induction of partial anergy was
the intestinal epithelium is in a constant state of turnover the result in the mucosa. Moreover, the split anergy
and renewal and is thus one of the most dynamic tissues observed in OT-I IEL from ova-bearing hosts represents
a distinct level of tolerance induction in vivo. In vitro, ain the body. The results suggested that tOVA or tOVA
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(N)-specific or OVA-specific CD8 T cells were detected using H-2KbCTL clone was unable to produce IL-2 in the absence
tetramers containing the N protein±derived peptide RGYVYQGL (Vanof costimulation, but lytic activity was retained (Otten
Bleek and Nathenson, 1990) or the ovalbumin-derived peptideand Germain, 1991). Also, long-lived male antigen-spe-
SIINFEKL (Carbone and Bevan, 1989). Peptides were purchased
cific splenic T cells and LCMV-specific CD8 T cells in from Research Genetics (Huntsville, AL). Tetramers were produced
antigen-bearing hosts are refractory to cytokine induc- essentially as previously described (Altman et al., 1996; Murali-
Krishna et al., 1998). Briefly, H-2Kb containing the BirA-dependenttion, but whether such cells were cytotoxic was not
biotinylation substrate sequence (the construct was generously pro-tested (Tanchot et al., 1998; Zajac et al., 1998). Perhaps
vided by John Altman, Emory University, Atlanta, GA) was folded inthe interaction of OT-I cells with antigen presented by
the presence of human b2-microglobulin and the N or OVA peptide.IEC, which do not express classical costimulators, re-
Biotinylation was performed with biotin-protein ligase (Avidity, Den-
sulted in nonresponsiveness. Overall, the tissue dynam- ver, CO). Tetramers were then produced from biotinylated HPLC-
ics of the intestinal epithelium and the ability to analyze purified monomers by addition of streptavidin-allophycocyanin
(APC, Molecular Probes, Eugene, OR).a tissue-resident population of autoreactive T cells out-
side of secondary lymphoid tissues provide powerful
tools for delineating mechanisms of tissue damage and
Flow Cytometric Analysis
tolerance induction. Lymphocytes were resuspended in PBS 0.2% BSA 0.1% NaN3 (PBS/
BSA/NaN3) at a concentration of 1 3 106 to 1 3 107 cells/ml followed
Experimental Procedures by incubation at 48C for 30 min with 100 ml of properly diluted mAb.
The mAbs were either directly labeled with fluorescein isothiocya-
Mice nate (FITC), phycoerythrin (PE), Cy5, APC, or were biotinylated. For
C57BL/6J (Ly5.1) mice were purchased from the Jackson Laboratory the latter, avidin-PE-Cy7 (Caltag, Burlingame, CA) was used as a
(Bar Harbor, ME). The OT-I mouse line (Hogquist et al., 1994) was secondary reagent for detection. For tetramer staining, cells were
generously provided by W. R. Heath (WEHI, Parkville, Australia) and first reacted with PE-labeled anti-CD8 (CalTag Laboratories) and
F. Carbone (Monash Medical School, Prahan, Victoria, Australia) and FITC-labeled anti-CD11a at 48C followed by staining for 1 hr at room
was maintained as a C57BL/6-Ly5.2 line on a RAG2/2 background. temperature with APC-coupled MHC tetramers. After staining, the
IFABP-tOVA transgenic mice were created using a construct con- cells were washed twice with PBS/BSA/NaN3 and fixed in 3% para-
taining the long form of the IFABP promoter (nucleotides 21178 to formaldehyde in PBS. Relative fluorescence intensities were then
128; a generous gift of J. I. Gordon, Washington University School measured with a FACScalibur (Becton-Dickinson, San Jose, CA).
of Medicine, St. Louis, MO) (Sweetser et al., 1988; Green et al., Data were analyzed using WinMDI software (Joseph Trotter, Scripps
1992), truncated OVA (tOVA) cDNA (encoding amino acids 138±386), Clinic, La Jolla, CA).
which does not include the signal sequence so the protein remains
cytosolic (Shastri and Gonzalez, 1993), and the human growth hor-
mone gene (nucleotides 498±2652; a gift of R. M. Perlmutter, Univer- Histological Analysis
sity of Washington, Seattle, WA) (Palmiter et al., 1991). A SalI frag- Duodenum, jejunum, and ileum from experimental animals were
ment containing these elements was microinjected into C57Bl/6- fixed in 10% formalin (Fisher Scientific, Pittsburgh, PA). Paraffin-
Ly5.1 fertilized eggs. To detect the transgene, genomic DNA was embedded tissue was sectioned and then stained with hematoxylin
analyzed by PCR to identify a 608 bp band using an IFABP-specific and eosin. For immunohistology, tissues were embedded in O. C. T.
59 primer (59-GCCATCACACTTGACCCTAA-39) and an OVA-specific medium and snap-frozen in liquid nitrogen. Six micron cryostat sec-
39 primer (59-TCAGGCAACAGCACCAACAT-39). Mice were kept in tions were reacted with biotinylated anti-Ly5.2 mAb followed by
specific pathogen-free housing and were analyzed between 8±10 detection using the TSA-amplification system according to manu-
weeks of age. facturer's instructions (New England Nuclear, Boston, MA). All im-
ages are magnified 2003.
RNA Analysis
Total RNA from the indicated tissues was isolated by cell lysis with
guanidine isothiocyanate followed by centrifugation over a cesium Measurement of Cytolytic Activity
chloride cushion (Chirgwin et al., 1979). Purification of poly(A) RNA Cytolytic activity was measured using [51Cr]sodium chromate EL4
was accomplished using a Poly(A) Quik mRNA Isolation Kit from cells (an H-2b thymoma) with or without the addition of 10 mg/ml of
Stratagene (La Jolla, CA) according to the manufacturer's instruc- the ova-derived peptide SIINFEKL. Serial dilutions of effector cells
tions. One microgram of poly(A) RNA was dot blotted onto a nylon were incubated in 96-well round bottom microtiter plates with 2.5 3
membrane that was then hybridized with a 32P-labeled OVA cDNA 103 target cells for 6 hr at 378C. Percent-specific lysis was calculated
fragment. The blot was stripped and reprobed with a GAPDH-spe- as follows: 100 3 [(c.p.m. released with effectors) 2 (c.p.m. released
cific cDNA probe to allow for mRNA quantitation. A Molecular Dy- alone)] / [(c.p.m. released by detergent) 2 (c.p.m. released alone)].
namics (Sunnyvale, CA) PhosphorImager was used to quantitate
hybridization.
Intracellular Detection of IFNg
IEL were isolated from OT-I-transferred VSV-ova immunized B6 miceIsolation of Lymphocyte Populations and Adoptive Transfer
of OVA-Specific CD8 T Cells or 232-6 IFABP-tOVA transgenic mice at the indicated times. Cells
were cultured in DMEM/5%FCS/10%Nu Serum (GIBCO±BRL) withIEL and LP cells were isolated as described previously (Goodman
and LefrancË ois, 1988; Laky et al., 1997). Lymph nodes (LN) and added HEPES, 2-mercaptoethanol, and antibiotics at a density of
1 3 106 cells/ml in a 24-well dish at 378C. To restimulate OT-I cells,spleens were removed and single cell suspensions were prepared.
Peripheral LN included brachial, axillary, and superficial inguinal cultures were treated with 1 mg/ml of SIINFEKL peptide. Golgiplug
(containing brefeldin A, PharMingen, San Diego, CA) was added tonodes. The resulting preparation was filtered through Nitex and the
filtrate centrifuged to pellet the cells. For adoptive transfer, 5 3 105 unstimulated and stimulated cultures at a dilution of 1 ml/ml. Cells
were harvested after 5 hr and stained for cell-surface antigens asOT-I/RAG2/2/Ly5.2 pooled LN cells were injected i.v. into Ly5.1 B6
or transgenic hosts. Where indicated, mice were infected 24 hr later previously described. Cells were then fixed in 4% paraformalde-
hyde/PBS for 20 min at 48C, washed twice, and stored overnight atby i.v. injection of 1 3 106 pfu vesicular stomatitis virus encoding
OVA (VSV-ova) (Kim et al., 1998). 48C. The next day, the cells were permeabilized by incubating in
Perm/Wash solution (PharMingen) for 20 min. The permeabilized
cells were incubated with anti-IFNg-FITC (XMG1.2, 5 mg/ml, Phar-Detection of Antigen-Specific CD8 T Cells
with MHC Tetramers Mingen) or control rat IgG1-FITC (R3-34, 5 mg/ml, PharMingen) for
30 min at 48C and washed twice in Perm/Wash solution. The fluores-Mice were infected by i.v. injection of 1 3 106 pfu of VSV-ova.
Six days later, lymphocytes were isolated and VSV nucleoprotein cence intensities were immediately measured on a FACScalibur.
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